Dubai-UAE: Dubai Science Park, a science-focused business community, hosted a panel discussion in partnership with CPhI Middle East & Africa, the region's most comprehensive pharma gathering, to discuss the importance of attracting manufacturing activities to the local pharmaceuticals and medical equipment sector and decrease dependency on medical imports.
Themed ‘Dubai Industrial Strategy 2030: Advancing the UAE pharmaceutical sector’, the session drew the participation of industry leaders including Ayman Mokhtar, Country Manager of the Gulf Region at Pfizer, Madhukar Tanna, CEO of Pharmax Pharmaceuticals, Christian Stoll, Licensing and Business Development Manager of Alfred E. Tiefenbacher, Dr Amjad Qandil, Professor and Quality Unit Chairman of the College of Pharmacy at King Saud bin Abdulaziz University for Health Science, and Prashant Pandarathil, Engagement Manager at IQVIA Dubai.
Leading the panel discussion as the moderator, Marwan Abdulaziz Janahi, Managing Director of Dubai Science Park, and Chairing Member of the Pharmaceutical and Medical Equipment Taskforce of the Dubai Industrial Strategy 2030, said: “The UAE government has an ongoing commitment to enhance the pharmaceutical sector in this region. The Dubai Industrial Strategy 2030 provides the necessary framework and incentives for us to identify, develop and promote the sector and look at the key enablers such as access to finance, availability of talent and the legal framework to pave the way for the sector.”
In turn, Ayman Mokhtar, Gulf Country Manager for Pfizer, one of the world’s premier innovative biopharmaceutical companies, expressed his happiness with the useful outcomes and recommendations of the discussion and said: “Pfizer has long recognised the necessity of creating a local industrial ecosystem that enables talented individuals to harness their potential and participate in achieving the country’s vision to develop local healthcare sectors. We emphasise the importance of effective partnerships with our partners in government, health care institutions and other sectors to ensure that patients have easy access to quality healthcare.”
Meanwhile, Dr Amjad Qandil underlined the importance of involving academia in the development of home-grown R&D capacities. He highlighted the growing need for a collaborative approach between industry leaders and students that ultimately leads to more innovation, productivity and ideation.
The CPhl Middle East and Africa event took place at the Abu Dhabi National Exhibitions Company (ADNEC), UAE. This will be followed by CPhI Worldwide in Spain from 9 to 11 October.
© Press Release 2018Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
